Xiaohui Niu, MD

Chief physician
Department of Orthopaedic Oncology Surgery, Beijing Ji Shui Tan Hospital, China (People's Republic)

Chief expert at the Department of Orthopedic Oncology Surgery, Beijing Ji Shui Tan Hospital.
Chairman of the Osteosarcoma Expert Committee of the Chinese Society of Clinical Oncology.
Chairman of the Sarcoma Professional Committee of the China Anti-Cancer Association.
Member of the Standing Committee of the International Malignant Bone Tumor Limb Salvage Society.

Poster(s):

• (P 168) A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEXIDARTINIB IN ASIAN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR

• (P 169) UPDATED EFFICACY AND SAFETY PROFILE OF PIMICOTINIB (ABSK021) IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): 1-YEAR FOLLOW-UP FROM PHASE 1B

• (P 543) MANEUVER STUDY: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF PIMICOTINIB (ABSK021) TO ASSESS THE EFFICACY AND SAFETY IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR